【預告】5/13(一)起，第三階段頁面上方功能列以及下方資訊全面更換新版。前往查看

專技 - 藥物治療學題庫 下載題庫

69 治療輕度類風濕性關節炎之第一線用藥選擇為：
(A) sulfasalazine
(B) corticosteroids
(C) methotrexate
(D) NSAIDs

專技 - 藥物治療學- 98 年 - 98-1 專技高考_藥師：藥物治療學#9946

答案：登入後觀看
難度： 簡單

討論
私人筆記( 0 )

查看全部4則討論

	2F Sky 大一上 (2020/02/01) 這題感覺要選MTX? Early use of DMARDs — We recommend that all patients diagnosed with RA be started on DMARD therapy as soon as possible. Our choice of drug therapies in patients with RA and the evidence supporting these choices is described in detail separately. Briefly, we take the following approach: ●In patients with active RA, we initiate antiinflammatory therapy with either a NSAID or glucocorticoid, depending upon the degree of disease activity, and generally start DMARD therapy with MTX. Patients unable to take MTX may require an alternative agent, such as HCQ, SSZ, or LEF. ... 查看完整內容這題感覺要選MTX? Early use of DMARDs — We recommend that all patients diagnosed with RA be started on DMARD therapy as soon as possible. Our choice of drug therapies in patients with RA and the evidence supporting these choices is described in detail separately. Briefly, we take the following approach: ●In patients with active RA, we initiate antiinflammatory therapy with either a NSAID or glucocorticoid, depending upon the degree of disease activity, and generally start DMARD therapy with MTX. Patients unable to take MTX may require an alternative agent, such as HCQ, SSZ, or LEF. ref:uptodate 檢舉
	3F 強力施巴大二上 (2021/04/27) 取自第11版Pharmacotherapy The current guidelines for treatment of RA recommend initiation of conventional DMARDs irrespective of disease activity in treatment-naive patients once a diagnosis is established. The preferred conventional DMARD is methotrexate unless a contraindication to its use exists.確診RA，首選MTX NSAIDs inhibit prostaglandin synthesis and can provide anti-inflammatory as well as analgesic effects. However, they do not slow disease progression and should not be used as monotherapy. NSAIDs can provide symptomatic relief of pain and stiffness and can be effective as adjuncts to D... 查看完整內容取自第11版Pharmacotherapy The current guidelines for treatment of RA recommend initiation of conventional DMARDs irrespective of disease activity in treatment-naive patients once a diagnosis is established. The preferred conventional DMARD is methotrexate unless a contraindication to its use exists.確診RA，首選MTX NSAIDs inhibit prostaglandin synthesis and can provide anti-inflammatory as well as analgesic effects. However, they do not slow disease progression and should not be used as monotherapy. NSAIDs can provide symptomatic relief of pain and stiffness and can be effective as adjuncts to DMARD therapy in patients with RA. They have a more rapid onset of action than DMARDs and may be beneficial to “bridge” patients while DMARDs take effect.NSAID僅作為DMARD尚未onset前的症狀治療檢舉
	4F 可不可高一上 (2021/07/23) 2021更新輕度應該是使用Sulfasalazine 取自Koda-kimble _Young’s applied Therapeutic 檢舉

你可以購買他人私人筆記。